Rapport Therapeutics, Inc. Common Stock (RAPP) is a publicly traded Healthcare sector company. As of July 16, 2026, RAPP trades at $39.95 with a market cap of $1.98B and a P/E ratio of -15.49. RAPP moved -3.76% today. Year to date, RAPP is +31.61%; over the trailing twelve months it is +177.68%. Its 52-week range spans $6.43 to $43.76. Analyst consensus is strong buy with an average price target of $53.71. Rallies surfaces RAPP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for RAPP, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $39.95 |
| Market Cap | $1.98B |
| P/E Ratio | -15.49 |
| EPS | $-2.59 |
| Dividend Yield | 0.00% |
| 52-Week High | $43.76 |
| 52-Week Low | $6.43 |
| Volume | 201.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $20.00M |
| Net Income | $-107.28M |
| Gross Margin | 0.00% |
8 analysts cover RAPP: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $53.71.